Background We investigated patterns in the time from recombinant tissue-type plasminogen
activator (rt-PA) treatment to symptomatic intracranial hemorrhage (sICH) onset in acute …

Background The American Heart Association/American Stroke Association (AHA/ASA)
recommended an expansion of the time window for acute ischemic stroke (AIS) reperfusion …

Background—Studies evaluating predictors of tPA-associated symptomatic intracerebral
hemorrhage (SICH) have typically focused on clinical and CT-based variables. MRI-based …

Background To describe the 4-year experience of symptomatic intracranial hemorrhage
(sICH) rate at a high-volume comprehensive stroke center. Methods All admitted adult (≥ 18 …

Background: Symptomatic intracerebral hemorrhage (sICH) is the most unfavorable
complication after IV thrombolytic treatment. We aimed to determine the relationship …

Background: According to current guidelines, stroke patients treated with rt-PA should
undergo brain imaging to exclude intracerebral bleeding 24 h after thrombolysis, before the …

Summary Background and Purpose: To evaluate risk factors for intracerebral hemorrhages
and the clinical effects of these hemorrhages in patients treated with recombinant tissue …

Reperfusion therapies are the mainstay of acute ischemic stroke (AIS) treatments and
overall improve functional outcome. Among the established complications of intravenous …

Introduction: Little is known about the timing of occurrence of symptomatic intracranial
hemorrhage (sICH) after endovascular therapy (EVT) for acute ischemic stroke. A better …

Background and purpose The optimal management of stroke patients who fail treatment with
intravenous recombinant tissue plasminogen activator (rt-PA) remains unknown. A study …